Pyxis Oncology, Inc.
Pharmaceutical Preparations · Boston, MA, United States
- PrincipalsThomas CivikInterim CEOand 8 more
- CompanyPyxis Oncology, Inc.Boston, MA, United States
- Phone line+1 (617) 221-9059General business
Pyxis Oncology, Inc. is an SEC-registered Nasdaq-listed company (ticker PYXS) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 9
Chief executive
Thomas CivikInterim CEO
Chair & board
Darren S ClineDirector (Board)
Freda C Lewis-HallDirector (Board)
Jakob DupontDirector (Board)
John L FlavinDirector (Board)
Everyone else on file (1)
Jitendra WadhanePrin Fin & Acct Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Jitendra Wadhane — Prin Fin & Acct Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Darren S Cline — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Freda C Lewis-Hall — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Thomas Civik — Interim CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Xenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityJazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capability